{{Rsnum
|rsid=9823506
|Gene=ABI3BP
|Chromosome=3
|position=100757869
|Orientation=plus
|GMAF=0.03122
|Gene_s=ABI3BP
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 98.5 | 1.5 | 0.0
| HCB | 100.0 | 0.0 | 0.0
| JPT | 99.1 | 0.9 | 0.0
| YRI | 76.9 | 21.8 | 1.4
| ASW | 80.0 | 18.2 | 1.8
| CHB | 100.0 | 0.0 | 0.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 94.5 | 5.5 | 0.0
| MKK | 84.3 | 15.0 | 0.7
| TSI | 96.9 | 3.1 | 0.0
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23829686
  |Trait=Asthma (childhood onset)
  |Title=Rank-based genome-wide analysis reveals the association of ryanodine receptor-2 gene variants with childhood asthma among human populations.
  |RiskAllele=
  |Pval=6E-8
  |OR=NR
  |ORtxt=NR
  |OA=1
}}

{{on chip | Affy GenomeWide 6}}